Microsampling tools for collecting, processing, and storing blood at the point-of-care
- PMID: 36925672
- PMCID: PMC10013775
- DOI: 10.1002/btm2.10476
Microsampling tools for collecting, processing, and storing blood at the point-of-care
Abstract
In the wake of the COVID-19 global pandemic, self-administered microsampling tools have reemerged as an effective means to maintain routine healthcare assessments without inundating hospitals or clinics. Finger-stick collection of blood is easily performed at home, in the workplace, or at the point-of-care, obviating the need for a trained phlebotomist. While the initial collection of blood is facile, the diagnostic or clinical utility of the sample is dependent on how the sample is processed and stored prior to transport to an analytical laboratory. The past decade has seen incredible innovation for the development of new materials and technologies to collect low-volume samples of blood with excellent precision that operate independently of the hematocrit effect. The final application of that blood (i.e., the test to be performed) ultimately dictates the collection and storage approach as certain materials or chemical reagents can render a sample diagnostically useless. Consequently, there is not a single microsampling tool that is capable of addressing every clinical need at this time. In this review, we highlight technologies designed for patient-centric microsampling blood at the point-of-care and discuss their utility for quantitative sampling as a function of collection material and technique. In addition to surveying methods for collecting and storing whole blood, we emphasize the need for direct separation of the cellular and liquid components of blood to produce cell-free plasma to expand clinical utility. Integrating advanced functionality while maintaining simple user operation presents a viable means of revolutionizing self-administered microsampling, establishing new avenues for innovation in materials science, and expanding access to healthcare.
Keywords: dried blood spot; microsampling; plasma separation; point‐of‐care; quality; volumetric.
© 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers.
Conflict of interest statement
Keith R. Baillargeon and Charles R. Mace are co‐inventors on patent applications for technologies related to blood and plasma microsampling devices.
Figures
References
-
- Wians HF. Clinical laboratory tests: which, why, and what do the results mean? Lab Med. 2009;40:105‐113.
-
- World Health Organization . Best practices in phlebotomy. WHO Guidelines on Drawing Blood: Best Practices in Phlebotomy. World Health Organization; 2010. https://www.ncbi.nlm.nih.gov/books/NBK138665/. Accessed September 2021 - PubMed
-
- World Health Organization . Annex 3, Collection, storage and shipment of specimens for laboratory diagnosis and interpretation of results. Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region. World Health Organization; 2012. https://www.ncbi.nlm.nih.gov/books/NBK143256/. Accessed June 2021 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
